Cite

HARVARD Citation

    Panaccione, R. et al. (2019). Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease Studies. Journal of Crohn's and colitis. pp. 725-734. [Online]. 
  
Back to record